Star Alliance International Corp. Signs Acquisition Agreement with HRaspirin, Ltd.

LAS VEGAS, NV / ACCESSWIRE / July 16, 2024 / Star Alliance International Corp. (OTC PINK:STAL) has announced that it has signed definitive documents to acquire 51% of HRaspirin. The acquisition will become effective on or before August 15, 2024, contingent upon the achievement of certain milestones.

Founded in 2018, HRaspirin addresses the challenges employers face in managing benefits. HRaspirin's proprietary software enables companies to provide voluntary benefits to employees without incurring carrier management costs. This solution is particularly valuable as businesses face budget cuts in human resources.

Shawn Stephens, President of HRaspirin, commented on the synergy with Star Alliance's vision for their Fintech division. He projected HRaspirin's revenue to reach approximately $2 million in 2024, with aspirations to hit $10 million in 2025, supported by Star Alliance's management and funding capabilities.

Richard Carey, President and Chairman of Star Alliance, highlighted that this acquisition supports their 2024 growth targets. It strengthens their Fintech division and aligns with their broader strategy, which includes mining operations and artificial intelligence initiatives.